Mirati Therapeutics, Inc. EPS - Earnings per Share 2013-2023 | MRTX
Mirati Therapeutics, Inc. eps - earnings per share from 2013 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Mirati Therapeutics, Inc. Annual EPS |
| 2022 |
$-13.18 |
| 2021 |
$-11.21 |
| 2020 |
$-7.96 |
| 2019 |
$-5.69 |
| 2018 |
$-3.19 |
| 2017 |
$-2.78 |
| 2016 |
$-4.20 |
| 2015 |
$-3.82 |
| 2014 |
$-3.24 |
| 2013 |
$-4.78 |
| 2012 |
$-3.00 |
| 2011 |
$-99.00 |
| Mirati Therapeutics, Inc. Quarterly EPS |
| 2023-09-30 |
$-2.49 |
| 2023-06-30 |
$-3.04 |
| 2023-03-31 |
$-3.18 |
| 2022-12-31 |
$-3.51 |
| 2022-09-30 |
$-3.09 |
| 2022-06-30 |
$-3.18 |
| 2022-03-31 |
$-3.40 |
| 2021-12-31 |
$-3.76 |
| 2021-09-30 |
$-1.55 |
| 2021-06-30 |
$-3.23 |
| 2021-03-31 |
$-2.67 |
| 2020-12-31 |
$-2.09 |
| 2020-09-30 |
$-1.96 |
| 2020-06-30 |
$-1.89 |
| 2020-03-31 |
$-2.02 |
| 2019-12-31 |
$-1.88 |
| 2019-09-30 |
$-1.38 |
| 2019-06-30 |
$-1.26 |
| 2019-03-31 |
$-1.17 |
| 2018-12-31 |
$-0.89 |
| 2018-09-30 |
$-0.85 |
| 2018-06-30 |
$-0.94 |
| 2018-03-31 |
$-0.51 |
| 2017-12-31 |
$-0.66 |
| 2017-09-30 |
$-0.65 |
| 2017-06-30 |
$-0.74 |
| 2017-03-31 |
$-0.73 |
| 2016-12-31 |
$-0.99 |
| 2016-09-30 |
$-0.97 |
| 2016-06-30 |
$-1.11 |
| 2016-03-31 |
$-1.13 |
| 2015-12-31 |
$-0.99 |
| 2015-09-30 |
$-1.11 |
| 2015-06-30 |
$-0.95 |
| 2015-03-31 |
$-0.77 |
| 2014-12-31 |
$-0.69 |
| 2014-09-30 |
$-0.72 |
| 2014-06-30 |
$-0.82 |
| 2014-03-31 |
$-1.01 |
| 2013-12-31 |
$-0.61 |
| 2013-09-30 |
$-2.95 |
| 2013-06-30 |
$-0.80 |
| 2013-03-31 |
$-0.42 |
| 2012-12-31 |
$-0.84 |
| 2012-09-30 |
$-0.93 |
| 2012-06-30 |
$-0.73 |
| 2012-03-31 |
$-0.50 |
